BONER locks up half of tokenized Hims & Hers supply on Robinhood Chain, briefly sending HIMS tok

Hims and Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today anno

SYDNEY--(BUSINESS WIRE)--Hims & Hers, the leading global health and wellness platform, today announc

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and

Telehealth company Hims & Hers said on Monday it has begun offering branded GLP-1 weight-loss drugs

New York, New York--(Newsfile Corp. - August 31, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

PHILADELPHIA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- National plaintiffs' law firm Berger Montague PC ann

Hims & Hers Health is building a vertically integrated consumer-health distribution platform, with v

The share price is up over 100% in the previous six months.

New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Hims & Hers approaches 3 million subscribers as U.S. growth reaccelerates and international markets

SAN FRANCISCO, Aug. 26, 2026 /PRNewswire/ -- On July 29, 2026, investors in Hims & Hers Health, Inc.

New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

Philadelphia, Pennsylvania--(Newsfile Corp. - August 26, 2026) - National plaintiffs' law firm Berge

For adults over the age of 55, including patients in Medicare's GLP-1 Bridge program, these lowe

LOS ANGELES, Aug. 25, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Hims & Hers Health, Inc.

BENSALEM, Pa., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its invest

LOS ANGELES, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national

Hims and Hers Health (HIMS) shares dipped about 8% Monday after reports that Visa had placed the tel

LOS ANGELES, Aug. 24, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its invest

The telehealth sector relies heavily on frictionless subscription models to sustain top-line growth.

Truist Securities analyst Jailendra Singh maintains Hims & Hers Health (NYSE:HIMS) with a Hol

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Barclays analyst Glen Santangelo maintains Hims & Hers Health (NYSE:HIMS) with a Overweight a

Hims & Hers CEO Andrew Dudum defends the firm against an FTC lawsuit, discusses dropping GLP-1 d

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Citigroup analyst Daniel Grosslight maintains Hims & Hers Health (NYSE:HIMS) with a Neutral a

Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and ra

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral

TD Cowen analyst Jonna Kim maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises th

Morgan Stanley analyst Craig Hettenbach maintains Hims & Hers Health (NYSE:HIMS) with a Equal

HIMS stock edges lower after mixed Q2 results. Needham analyst maintains Buy rating, raises PT to $4

Hims & Hers stock falls after Q2 earnings miss estimates despite beating revenue targets. Here i

U.S. stock futures mostly lower. OppFi (OPFI) shares fall after missing Q2 earnings and cutting FY26

Needham analyst Ryan MacDonald maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises

RKLB, HIMS, ASTS, ACHR, PLUG were among the stocks seen trending on Monday, Aug. 10, 2026.

Hims & Hers posted Q2 results - here are the details you need to know.

Hims & Hers Health (NYSE:HIMS) sees Q3 sales of $880.000 million-$900.000 million vs $793.071 mi

Hims & Hers Health (NYSE:HIMS) raises FY2026 sales outlook from $2.800 billion-$3.000 billion to

Hims & Hers Health (NYSE:HIMS) reported quarterly losses of $(0.37) per share which missed the a

Hims & Hers Health shares are in the spotlight Monday ahead of its second-quarter earnings repor

HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted

Rebuilt from the ground up, the new Hers app puts women in one continuous conversation with their pr

CVS Pharmacy offers all FDA approved GLP-1s, whether through insurance or cash-pay options.New colla

Hims & Hers Health shares are trading higher Friday as traders continue to weigh fresh regulator

First commercial offering from Dario's collaboration with Beluga Health adds licensed provider e

The FTC is suing Hims & Hers for allegedly sharing user health data with advertisers and engagin

Jim Cramer likes Ross Stores (ROST) on CNBC's Mad Money Lightning Round. Ross Stores reported st

Truist Securities analyst Jailendra Singh maintains Hims & Hers Health (NYSE:HIMS) with a Hol